Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up
stock market news, nxgen brands inc acquires exclusive license to utili 8386653890827187

ADMP - Adamis Pharmaceuticals Corporation Stock Trading


home / stock / admp

Adamis Pharmaceuticals Corporation(NASDAQ: ADMP) stock trading, description, contact, officers and directors.
About Adamis Pharmaceuticals Corporation
Adamis Pharmaceuticals Corporation is a publicly traded OTC: ADMP biopharmaceutical company combining specialty pharmaceuticals and biotechnology products to create a variety of treatment options in the areas of oncology cancer , immunology, infectious diseases viruses , as well as allergic and respiratory conditions. Adamis is built on a business model that entails licensing innovative programs from companies or institutions and then advancing these initiatives through clinical development, regulatory approvals, and marketing. In order to efficiently accomplish its objectives, the Company operates through two subsidiaries Adamis Laboratories specialty pharmaceuticals and Adamis Therapeutics biotechnology . This structure permits each division to complement one other by providing a combination of pharmaceutical revenue and biotechnology blockbuster potential. The specialty pharmaceutical division will provide revenue to support the development of the Company s therapeutic products.
Stock Information

Adamis Pharmaceuticals Corporation Company Name:

ADMP Stock Symbol:

NASDAQ Market:

Adamis Pharmaceuticals Corporation Website:

MENU
ADMP ADMP Quote ADMP Short ADMP News ADMP Articles ADMP Message Board
Get ADMP Alerts

News, Short Squeeze, Breakout and More Instantly...

stock market news, nxgen brands inc acquires exclusive license to utili 8386653890827187
RECENT ADMP NEWS
  • ADMP - SYMJEPI Products Now Available in the Walgreens Prescription Savings Club, with the Lowest Prices for Epinephrine Products

    SAN DIEGO, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that its SYMJEPI ® (epinephrine) Injection products are now available to members of the Walgreens Prescription Savings Club program, for a discounted price of $99....

  • ADMP - "The Buzz" Show: Adamis Pharmaceuticals (NASDAQ: ADMP) IND Submission to FDA for Covid-19 Treatment

    FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “ Adamis Pharmaceuticals Skyrockets Amid IND Submission to FDA for Covid-19 Treatment” Adamis Pharmaceuticals (NASDAQ: ADMP) shot up over 27% in prema...

  • ADMP - Penny Stocks Are Red Hot But Is Now The Right Time To Buy?

    Traders Are Flocking To Penny Stocks In Droves Penny stocks are shining bright right now. It doesn’t matter the day of the week or the stock price so long as it’s cheap. Every week we see these low-priced stocks dominating the top 10 most active list. On Tuesday, 7 out...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Member Benefits
  • Member Coins
  • Sign Up
  • Login
  • Contact
x
stock market news, nxgen brands inc acquires exclusive license to utili 8386653890827187

Important Investor Video Alert (OTCMKTS: NXGB)

  • NXGB - NxGen Brands, Inc. Acquires Exclusive License To Utilize & Market Various High Demand Technologies

    NxGen Brands, Inc. Acquires Exclusive License To Utilize & Market Various High Demand Technologies NxGen Brands, Inc. Acquires Exclusive License To Utilize & Market Various High Demand Technologies The Technology Largely Involves Advanced GPS Tracking And Associated ...

Sign up or login to continue

Sign up or login to continue.




WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Member Benefits

Member Coins


Log In

Sign Up

Stay Connected
Follow @marketWN

Contact

Privacy

Terms of Service

Disclaimer

© 2020 Market Wire News